Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (427)	1/17/1999 4:43:00 PM
From: LLCF	Read Replies (1) \| Respond to of 1073

Anyone watching ENZN (Piscataway N.J.), drug delivery "PEG"ed molecules company? Schearing Plough has "PEG INTRON A" finished (I believe) Phase III and readying the NDA for Hep C to supposedly replace its own INTON A for the same indication (which has 6-7 hundred million in sales but has competition) They have also started Phase 3 for several other indications. It's had quite a run and I've actually sold some of my stake but I'm hearing the Hep C drug alone is worth $30 a share (last $15) and the company comes with a few other promising "tidbits". enzon.com Supposedly an article in "Time" about Sch.Plough and this drug, I havent picked it up yet. Would love any input from those in the know... I am a layperson and NOT familiar with the science except that "Pegged" molecules supposedly stay effective longer and lessen side effects, at least in some cases: enzon.com There are others using Peg technology, but supposedly ENZON is way out front with 2nd and 3rd generation patents and superior technology (company "puffery"?). DAK DAK